Incidence of testicular cancer in the united states, 1999-2004

American Journal of Men's Health

Volumn 4, Issue 4, 2010, Pages 353-360

  Townsend, Julie S ^a   Richardson, Lisa C ^a   German, Robert R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

epidemiology; health status disparities; incidence; public health; testicular cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; CANCER REGISTRY; CANCER STAGING; CAUCASIAN; ETHNIC GROUP; ETHNOLOGY; HISPANIC; HUMAN; INCIDENCE; MALE; MEN'S HEALTH; MIDDLE AGED; RACE; RISK FACTOR; STATISTICS; TESTIS TUMOR; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; ASIAN AMERICANS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; MALE; MEN'S HEALTH; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; SEER PROGRAM; TESTICULAR NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 78649974536     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988309356101     Document Type: Article

References (31)

1. American Academy of Family Physicians. (2007). Summary of recommendations for clinical preventive services. Revision 6.4. Leawood, KS: Author.
2. Biggs, M.L., & Schwartz, S.M. (2004). Differences in testis cancer survival by race and ethnicity: A population-based study, 1973-1999 (United States). Cancer Causes & Control, 15, 437-444.
3. Centers for Disease Control and Prevention. (1999). The National Program of Cancer Registries-Cancer surveillance system rationale and approach. Atlanta, GA: Author. Retrieved October 14, 2009, fromhttp://www.cdc.gov/cancer/npcr/training/css.htm.
4. Centers for Disease Control and Prevention. (2005). Behavioral Risk Factor Surveillance System survey data. Atlanta, GA: Author. Retrieved August 24, 2009, fromhttp://apps.nccd.cdc.gov/s_broker/htmsql.exe/weat/index.hsql.
5. Espey, D.K., Wiggins, C.L., Jim, M.A., Miller, B.A., Johnson, C.J., & Becker, T.M. (2008). Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer, 113(5, Suppl.), 1120-1130.
6. Feldman, D.R., Bosl, G.J., Sheinfeld, J., & Motzer, R.J. (2008). Medical treatment of advanced testicular cancer. Journal of the American Medical Association, 299, 672-684.
7. Garner, M.J., Turner, M.C., Ghadirian, P., & Krewski, D. (2005). Epidemiology of testicular cancer: An overview. International Journal of Cancer, 116, 331-339.
8. Halpern, M.T., Ward, E.M., Pavluck, A.L., Schrag, N.M., Bian, J., & Chen, A.Y. (2008). Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: A retrospective analysis. Lancet Oncology, 9, 222-231.
9. Harlan, L.C., Greene, A.L., Clegg, L.X., Mooney, M., Stevens, J.L., & Brown, M.L. (2005). Insurance status and the use of guideline therapy in the treatment of selected cancers. Journal of Clinical Oncology, 23, 9079-9088.
10. Huyghe, E., Matsuda, T., & Thonneau, P. (2003). Increasing incidence of testicular cancer worldwide: A review. Journal of Urology, 170, 5-11.
11. LutkeHolzik, M.F., Rapley, E.A., Hoekstra, H.J., Sleijfer, D.T., Nolte, I.M., & Sijmons, R.H. (2004). Genetic predisposition to testicular germ-cell tumours. Lancet Oncology, 5, 363-371.
12. Mackay, J., Jemal, A., Lee, N.C., & Parkin, D.M. (2006). The cancer atlas. Atlanta, GA: American Cancer Society. Retrieved June 18, 2009, fromhttp://www.cancer.org/docroot/AA/content/AA_2_5_9x_Cancer_Atlas.asp.
13. Martin, S., Ulrich, C., Munsell, M., Taylor, S., Lange, G., & Bleyer, A. (2007). Delays in cancer diagnosis in underinsured young adults and older adolescents. The Oncologist, 12, 816-824.
14. McGlynn, K.A., Devesa, S.S., Graubard, B.I., & Castle, P.E. (2005). Increasing incidence of testicular germ cell tumors among black men in the United States. Journal of Clinical Oncology, 23, 5757-5761.
15. McGlynn, K.A., Devesa, S.S., Sigurdson, A.J., Brown, L.M., Tsao, L., & Tarone, R.E. (2003). Trends in the incidence of testicular germ cell tumors in the United States. Cancer, 97, 63-70.
16. McGlynn, K.A., Graubard, B.I., Klebanoff, M.A., & Longnecker, M.P. (2006). Risk factors for cryptorchism among populations at differing risks of testicular cancer. International Journal of Epidemiology, 35, 787-795.
17. McKiernan, J.M., Goluboff, E.T., Liberson, G.L., Golden, R., & Fisch, H. (1999). Rising risk of testicular cancer by birth cohort in the United States from1973 to 1995. Journal of Urology, 162, 361-363.
18. Molineros, J.E., Kim-Howard, X., Deshmukh, H., Jacob, C.O., Harley, J.B., & Nath, S.K. (2009). Admixture in Hispanic Americans: Its impact on ITGAM association and implications for admixture mapping in SLE. Genes and Immunity, 10, 539-545.
19. Myrup, C., Westergaard, T., Schnack, T., Oudin, A., Ritz, C., & Wohlfahrt, J.,et al.(2008). Testicular cancer risk in first-and second-generation immigrants to Denmark. Journal of the National Cancer Institute, 100, 41-47.
20. NAACR Latino Research Workgroup. (2005). NAACCR guideline for enhancing Hispanic/Latino identification: Revised NAACCR Hispanic/Latino identification algorithm (NHIA v2). Springfield, IL: North American Association of Central Cancer Registries. Retrieved July 25, 2008, fromhttp://www.naaccr.org/filesystem/pdf/NHIA%20v2%2009-21-05.pdf.
21. National Cancer Institute. (2006). Surveillance epidemiology and end results (SEER) data submission requirements. Bethesda, MD: Author. Retrieved November 18, 2008, from http://seer.cancer.gov/tools/submission.html.
22. National Cancer Institute. (2008). Introduction to SEER*Stat. Bethesda, MD: Author. Retrieved November 26, 2008, fromhttp://seer.cancer.gov/seerstat/WebHelp/seerstat.htm#Trend_Algorithms.htm.
23. National Cancer Institute. (2009). Population estimates used in NCI's SEER*Stat software. Bethesda, MD: Author. Retrieved June 12, 2009, fromhttp://seer.cancer.gov/popdata/methods.html.
24. Nicholson, J.L., Collins, S.R., Mahato, B., Gould, E., Schoen, C., & Rustgi, S.D. (2009). Rite of passage? Why young adults become uninsured and how new policies can help, 2009 update. New York: Commonwealth Fund. Retrieved August 24, 2009, fromhttp://www.commonwealthfund.org/Content/Publications/Issue-Briefs/2009/Aug/Rite-of-Passage-Why-Young-Adults-Become-Uninsured-and-How-New-Policies-Can-Help-2009-Update.aspx.
25. Potischman, N., Troisi, R., Thadhani, R., Hoover, R.N., Dodd, K., & Davis, W.W.,et al.(2005). Pregnancy hormone concentrations across ethnic groups: Implications for later cancer risk. Cancer Epidemiology, Biomarkers & Prevention, 14, 1514-1520.
26. Purdue, M.P., Devesa, S.S., Sigurdson, A.J., & McGlynn, K.A. (2005). International patterns and trends in testis cancer incidence. International Journal of Cancer, 115, 822-827.
27. Richardson, L.C., Wingo, P.A., Zack, M.M., Zahran, H.S., & King, J.B. (2008). Health-related quality of life in cancer survivors between ages 20 and 64 years: Population-based estimates fromthe Behavioral Risk Factor Surveillance System. Cancer, 112, 1380-1389.
28. Shah, M.N., Devesa, S.S., Zhu, K., & McGlynn, K.A. (2007). Trends in testicular germ cell tumours by ethnic group in the United States. International Journal of Andrology, 30, 206-213.
29. U.S. Cancer Statistics Working Group. (2008). United States cancer statistics: 2004 incidence and mortality. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Retrieved July 25, 2008, fromhttp://www.cdc.gov/cancer/npcr/uscs/.
30. U.S. Preventive Services Task Force. (2004). Screening for testicular cancer. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved October 6, 2008, fromhttp://www.ahrq.gov/clinic/uspstf/uspstest.htm.
31. Weir, H.K., Marrett, L.D., & Moravan, V. (1999). Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996. Canadian Medical Association Journal, 160, 201-205.